This “Year in review” presents a selection of research themes and individual studies from the
clinical osteoarthritis (OA) field (epidemiology and therapy) and includes noteworthy …

Osteoarthritis, as a degenerative disease, is a common problem and results in high
socioeconomic costs and rates of disability. The most commonly affected joint is the knee …

Osteoarthritis (OA) is a degenerative multifactorial disease with concomitant structural,
inflammatory, and metabolic changes that fluctuate in a temporal and patient-specific …

Background Intra-articular injection of mesenchymal stromal cells (MSCs) with
immunomodulatory features and their paracrine secretion of regenerative factors proposed a …

Knee osteoarthritis presents higher incidences than other joints, with increased prevalence
during aging. It is a progressive process and may eventually lead to disability. Mesenchymal …

Osteoarthritis (OA) is a whole-joint disease primarily characterized by the deterioration of
hyaline cartilage. Current treatments include microfracture and chondrocyte implantation as …

Background In recent years, platelet-rich plasma (PRP) injections for osteoarthritis (OA)
have been widely promoted in clinical practice, but their effectiveness is controversial …

Background Mesenchymal stromal cells are a safe and promising option to treat knee
osteoarthritis as previously demonstrated in different clinical trials. However, their efficacy …

Objective Stem cell therapy is increasingly used for knee osteoarthritis (KOA). We aimed to
review the evidence of autologous mesenchymal stem cell therapy on pain, function and …

BACKGROUND Osteoarthritis (OA) is the most common joint disorder, is associated with an
increasing socioeconomic impact owing to the ageing population. AIM To analyze and …